Q4 FY2025 Earnings
Financial report interval: 2025.10.01 - 2025.12.31
Overview: Terns Pharmaceuticals(TERN) the EBIT is -27.6 M (-6.35%);the EPS is -0.241 (-0.76%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.03B6.35%
----
----
EPS
-0.24070.76%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf